BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30842218)

  • 1. The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation.
    Palangat M; Anastasakis DG; Fei DL; Lindblad KE; Bradley R; Hourigan CS; Hafner M; Larson DR
    Genes Dev; 2019 May; 33(9-10):482-497. PubMed ID: 30842218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation.
    Akef A; McGraw K; Cappell SD; Larson DR
    PLoS Biol; 2020 Nov; 18(11):e3000920. PubMed ID: 33137094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
    Brooks AN; Choi PS; de Waal L; Sharifnia T; Imielinski M; Saksena G; Pedamallu CS; Sivachenko A; Rosenberg M; Chmielecki J; Lawrence MS; DeLuca DS; Getz G; Meyerson M
    PLoS One; 2014; 9(1):e87361. PubMed ID: 24498085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant U2AF1-induced alternative splicing of H2afy (macroH2A1) regulates B-lymphopoiesis in mice.
    Kim SP; Srivatsan SN; Chavez M; Shirai CL; White BS; Ahmed T; Alberti MO; Shao J; Nunley R; White LS; Bednarski J; Pehrson JR; Walter MJ
    Cell Rep; 2021 Aug; 36(9):109626. PubMed ID: 34469727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome.
    Shirai CL; White BS; Tripathi M; Tapia R; Ley JN; Ndonwi M; Kim S; Shao J; Carver A; Saez B; Fulton RS; Fronick C; O'Laughlin M; Lagisetti C; Webb TR; Graubert TA; Walter MJ
    Nat Commun; 2017 Jan; 8():14060. PubMed ID: 28067246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival.
    Fei DL; Motowski H; Chatrikhi R; Prasad S; Yu J; Gao S; Kielkopf CL; Bradley RK; Varmus H
    PLoS Genet; 2016 Oct; 12(10):e1006384. PubMed ID: 27776121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene
    Fei DL; Zhen T; Durham B; Ferrarone J; Zhang T; Garrett L; Yoshimi A; Abdel-Wahab O; Bradley RK; Liu P; Varmus H
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10437-E10446. PubMed ID: 30322915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A splice site-sensing conformational switch in U2AF2 is modulated by U2AF1 and its recurrent myelodysplasia-associated mutation.
    Warnasooriya C; Feeney CF; Laird KM; Ermolenko DN; Kielkopf CL
    Nucleic Acids Res; 2020 Jun; 48(10):5695-5709. PubMed ID: 32343311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of U2AF1 S34F mutations in lung adenocarcinomas.
    Esfahani MS; Lee LJ; Jeon YJ; Flynn RA; Stehr H; Hui AB; Ishisoko N; Kildebeck E; Newman AM; Bratman SV; Porteus MH; Chang HY; Alizadeh AA; Diehn M
    Nat Commun; 2019 Dec; 10(1):5712. PubMed ID: 31836708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Profiling of Alternative Splicing Induced by
    Kim S; Park C; Jun Y; Lee S; Jung Y; Kim J
    Mol Cells; 2018 Aug; 41(8):733-741. PubMed ID: 29991672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U2AF1 mutation connects DNA damage to the alternative splicing of RAD51 in lung adenocarcinomas.
    Chen C; Zhou P; Zhang Z; Liu Y
    Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):740-747. PubMed ID: 35434831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of the aberrant 3' splice site selection by cancer-associated mutations on the U2AF1.
    Yoshida H; Park SY; Sakashita G; Nariai Y; Kuwasako K; Muto Y; Urano T; Obayashi E
    Nat Commun; 2020 Sep; 11(1):4744. PubMed ID: 32958768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia.
    Jin P; Wang X; Jin Q; Zhang Y; Shen J; Jiang G; Zhu H; Zhao M; Wang D; Li Z; Zhou Y; Li W; Zhang W; Liu Y; Wang S; Jin W; Cao Y; Sheng G; Dong F; Wu S; Li X; Jin Z; He M; Liu X; Chen L; Zhang Y; Wang K; Li J
    Cancer Res; 2024 May; 84(10):1583-1596. PubMed ID: 38417135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splicing Factor Mutations in Cancer.
    Bejar R
    Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.
    Shirai CL; Ley JN; White BS; Kim S; Tibbitts J; Shao J; Ndonwi M; Wadugu B; Duncavage EJ; Okeyo-Owuor T; Liu T; Griffith M; McGrath S; Magrini V; Fulton RS; Fronick C; O'Laughlin M; Graubert TA; Walter MJ
    Cancer Cell; 2015 May; 27(5):631-43. PubMed ID: 25965570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxynivalenol globally affects the selection of 3' splice sites in human cells by suppressing the splicing factors, U2AF1 and SF1.
    Hu Z; Sun Y; Chen J; Zhao Y; Qiao H; Chen R; Wen X; Deng Y; Wen J
    RNA Biol; 2020 Apr; 17(4):584-595. PubMed ID: 31992135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies.
    Biancon G; Joshi P; Zimmer JT; Hunck T; Gao Y; Lessard MD; Courchaine E; Barentine AES; Machyna M; Botti V; Qin A; Gbyli R; Patel A; Song Y; Kiefer L; Viero G; Neuenkirchen N; Lin H; Bewersdorf J; Simon MD; Neugebauer KM; Tebaldi T; Halene S
    Mol Cell; 2022 Mar; 82(6):1107-1122.e7. PubMed ID: 35303483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full-length transcript alterations in human bronchial epithelial cells with
    Soulette CM; Hrabeta-Robinson E; Arevalo C; Felton C; Tang AD; Marin MG; Brooks AN
    Life Sci Alliance; 2023 Oct; 6(10):. PubMed ID: 37487637
    [No Abstract]   [Full Text] [Related]  

  • 19. Down regulation of U2AF1 promotes ARV7 splicing and prostate cancer progression.
    Cao H; Wang D; Gao R; Chen L; Feng Y
    Biochem Biophys Res Commun; 2021 Feb; 541():56-62. PubMed ID: 33477033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Alternative Splicing in U2af1/Tet2 Double Mutant Mice Contributes to Major Hematological Phenotypes.
    Martínez-Valiente C; Garcia-Ruiz C; Rosón B; Liquori A; González-Romero E; Fernández-González R; Gómez-Redondo I; Cervera J; Gutiérrez-Adán A; Sanjuan-Pla A
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.